Youngy Health Co., Ltd. (300247) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Youngy Health Co., Ltd. has changed its score on 26 Nov 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a growth in Net Profit of 110.68%, the company declared Very Positive results in Mar 25

The company has declared positive results for the last 6 consecutive quarters
DEBTORS TURNOVER RATIO(HY) Highest at 14.51%
RAW MATERIAL COST(Y) Fallen by -15.74% (YoY)
CASH AND EQV(HY) Highest at CNY 1,312.1 MM

With ROE of 7.74%, it has a attractive valuation with a 2.30 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Tour, Travel Related Services

Market cap

CNY 2,564 Million (Small Cap)

P/E

30.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.65

Return on Equity

7.74%

Price to Book

2.30

Revenue and Profits:

Net Sales:

179 Million

(Quarterly Results - Jun 2025)

Net Profit:

21 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

11.7%

6 Months

20.84%

1 Year

13.52%

2 Years

29.87%

3 Years

26.82%

4 Years

27.82%

5 Years

51.71%

Youngy Health Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

5.14%

EBIT Growth (5y)

17.50%

EBIT to Interest (avg)

33.28

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.57

Sales to Capital Employed (avg)

0.57

Tax Ratio

25.24%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

6.86%

ROE (avg)

5.32%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.30

EV to EBIT

19.43

EV to EBITDA

15.10

EV to Capital Employed

4.76

EV to Sales

2.35

PEG Ratio

0.28

Dividend Yield

ROCE (Latest)

24.49%

ROE (Latest)

7.74%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 15.19% vs 39.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 75.83% vs -12.41% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "179.00",
          "val2": "155.40",
          "chgp": "15.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.50",
          "val2": "17.00",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.60",
          "val2": "2.10",
          "chgp": "71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.10",
          "val2": "12.00",
          "chgp": "75.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "108.40%",
          "val2": "64.30%",
          "chgp": "4.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 30.39% vs 14.37% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 57.76% vs -68.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "684.00",
          "val2": "524.60",
          "chgp": "30.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "91.70",
          "val2": "61.80",
          "chgp": "48.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "2.40",
          "chgp": "-58.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.70",
          "val2": "14.00",
          "chgp": "-59.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "66.10",
          "val2": "41.90",
          "chgp": "57.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "91.80%",
          "val2": "63.90%",
          "chgp": "2.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

179.00

155.40

15.19%

Operating Profit (PBDIT) excl Other Income

25.50

17.00

50.00%

Interest

0.00

Exceptional Items

3.60

2.10

71.43%

Consolidate Net Profit

21.10

12.00

75.83%

Operating Profit Margin (Excl OI)

108.40%

64.30%

4.41%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 15.19% vs 39.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 75.83% vs -12.41% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

684.00

524.60

30.39%

Operating Profit (PBDIT) excl Other Income

91.70

61.80

48.38%

Interest

1.00

2.40

-58.33%

Exceptional Items

5.70

14.00

-59.29%

Consolidate Net Profit

66.10

41.90

57.76%

Operating Profit Margin (Excl OI)

91.80%

63.90%

2.79%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 30.39% vs 14.37% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 57.76% vs -68.57% in Dec 2023

All Annual Results

Company CV

About Youngy Health Co., Ltd.

Youngy Health Co., Ltd.

Tour, Travel Related Services

No Details Available.

Company Coordinates

No Company Details Available